Mubadala Investment buys Amana Healthcare
Mubadala Investment Company has acquired Amana Healthcare. Amana Healthcare is a leading provider of long term care, specialized rehabilitation and home healthcare services.
Amana Healthcare was founded in Abu Dhabi. It is the first healthcare provider in the Middle East. It manages hospital in Abu Dhabi and Al Ain. It also offer world class servicces. The acquisition of Amana Healthcare’in expands the Mubadala Healthcare Network. It includes Cleveland Clinic Abu Dhabi, London Diabetes Centre, National Reference Laboratory and Healthpoint.
Latham Watkins and Allen & Overy supported the transaction as legal counsels, Bank of America Merrill Lynch as sell-side advisor, and Deloitte as tax and accounting advisors.
Waleed Al Mokarrab Al Muhairi, Mubadala deputy group CEO and chief executive officer, Alternative Investments & Infrastructure said: “We are excited to enter the next phase of growth with Mubadala Healthcare and the acquisition of Amana Healthcare will drive innovation while expanding the continuum of care for the UAE market. This is the first investment by Mubadala Healthcare in a UAE-based health services company, and we will certainty continue to look for the right acquisition opportunities, both on a regional and international level, to further bolster our portfolio of healthcare assets.”
Abdulla Abdul Aziz Al Shamsi, head of Mubadala Healthcare, added: “The acquisition of Amana Healthcare gives Mubadala’s customers the benefit of extended continuum-of-care services, all of which contribute to our vision of a world-class integrated health system for the people in the UAE. The acquisition also validates the Emirate of Abu Dhabi’s investment promotion strategy, under which the founders of Amana Healthcare developed an outstanding specialized healthcare provider that operates to the highest international standards.”
Mubadala Healthcare is supporting the development of a world class, commercially sustainable private healthcare sector in the UAE.
Source: Trade Arabia
Fulya Altunyay/ [email protected]